Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Diseases

Free Subscription 08.04.2024 1 AJR Am J Roentgenol 4 Am J Gastroenterol 1 Biochem Biophys Res Commun 1 BMC Gastroenterol 2 Dig Dis Sci 5 Hepatology 1 Int J Cancer 3 J Gastroenterol Hepatol 2 J Hepatol 6 PLoS One 1 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. CALLIADA F
   Editorial Comment: Multiparametric Ultrasound Assessment of Hepatic Fat Fraction in a Real-World Population.
   AJR Am J Roentgenol. 2024 Apr 3. doi: 10.2214/AJR.24.31226.
   PubMed        
   
   

   
   Am J Gastroenterol

2. PRICE JC, Springer G, Seaberg EC, Budoff MJ, et al
   High incidence rate of CT-measured steatotic liver disease in men with and without HIV infection.
   Am J Gastroenterol. 2023 Dec 22. doi: 10.14309/ajg.0000000000002633.
   PubMed         Abstract available
   
   
3. SILKE L, Donata G, Dominik G, Uli F, et al
   Endoscopic features of post-COVID-19 cholangiopathy and its management using ERCP.
   Am J Gastroenterol. 2023 Oct 16. doi: 10.14309/ajg.0000000000002562.
   PubMed         Abstract available
   
   
4. KHANNA S, Shah NL, Argo CK
   Use of Phosphatidylethanol Testing in Patients With Liver Disease.
   Am J Gastroenterol. 2024;119:596-599.
   PubMed        
   
   
5. PERUMALSWAMI PV, Winder GS, Fernandez AC, Mellinger JL, et al
   Practical Considerations to Optimize Care for Patients With Alcohol-Associated Liver Disease in General Gastroenterology Practice.
   Am J Gastroenterol. 2024;119:591-595.
   PubMed        
   
   

   
   Biochem Biophys Res Commun

6. ZHENG E, Chen Q, Xiao A, Luo X, et al
   Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2 signaling pathway.
   Biochem Biophys Res Commun. 2024;707:149781.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

7. TADOKORO T, Nomura T, Fujita K, Manabe T, et al
   Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients.
   BMC Gastroenterol. 2024;24:123.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

8. PEARLMAN BL
   Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis.
   Dig Dis Sci. 2024 Apr 5. doi: 10.1007/s10620-024-08393.
   PubMed         Abstract available
   
   
9. WANG H, Liu X, Xie Y, Qin X, et al
   A Case of Immunoglobulin Light Chain Hepatic Amyloidosis with Abdominal Hematoma.
   Dig Dis Sci. 2024 Mar 30. doi: 10.1007/s10620-024-08342.
   PubMed        
   
   

   
   Hepatology

10. 
    Erratum: AASLD Practice Guidance on Acute-on-chronic liver failure and the management of critically ill patients with cirrhosis.
    Hepatology. 2024 Mar 29. doi: 10.1097/HEP.0000000000000857.
    PubMed        
    
    
11. TAPPER EB, Warner MA, Shah RP, Emamaullee J, et al
    Management of coagulopathy among patients with cirrhosis undergoing upper endoscopy and paracentesis: Persistent gaps and areas of consensus in a multispecialty Delphi.
    Hepatology. 2024 Apr 1. doi: 10.1097/HEP.0000000000000856.
    PubMed         Abstract available
    
    
12. TAFALENG EN, Li J, Wang Y, Hidvegi T, et al
    Variants in autophagy genes MTMR12 and FAM134A are putative modifiers of the hepatic phenotype in alpha1-antitrypsin deficiency.
    Hepatology. 2024 Apr 1. doi: 10.1097/HEP.0000000000000865.
    PubMed         Abstract available
    
    
13. SUN C, Zhou C, Daneshvar K, Ben Saad A, et al
    Conserved long noncoding RNA TILAM promotes liver fibrosis through interaction with PML in hepatic stellate cells.
    Hepatology. 2024 Apr 2. doi: 10.1097/HEP.0000000000000822.
    PubMed         Abstract available
    
    
14. 
    Hepatology Highlights.
    Hepatology. 2024;79:525-526.
    PubMed        
    
    

    
    Int J Cancer

15. KARA-ALI GH, Cano L, Dion S, Imerzoukene G, et al
    Trim21 deficiency in mice increases HCC carcinogenesis in a NASH context and is associated with immune checkpoint upregulation.
    Int J Cancer. 2024;154:1999-2013.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

16. CHAN WK, George J
    Metabolic fatty liver syndromes: where do we stand in 2024?
    J Gastroenterol Hepatol. 2024;39:613-614.
    PubMed        
    
    
17. PARENTE A, Milana F, Hajibandeh S, Hajibandeh S, et al
    Clinical outcomes after transplantation of domino grafts or standard deceased donor livers: a systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2024;39:620-629.
    PubMed         Abstract available
    
    
18. SOGABE M, Okahisa T, Kagawa M, Sei M, et al
    Association of metabolic dysfunction-associated fatty liver disease with gallstone development: A longitudinal study.
    J Gastroenterol Hepatol. 2024 Jan 11. doi: 10.1111/jgh.16483.
    PubMed         Abstract available
    
    

    
    J Hepatol

19. CHAN SL, Ryoo BY, Mo F, Chan LL, et al
    Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment.
    J Hepatol. 2024 Mar 26:S0168-8278(24)00216-2. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available
    
    
20. HEUSCHKEL MJ, Bach C, Meiss-Heydmann L, Gerges E, et al
    Erratum to 'JAK1 promotes HDV replication and is a potential target for antiviral therapy' [J Hepatol 80 (2024) 220-231].
    J Hepatol. 2024 Mar 30:S0168-8278(24)00165-X. doi: 10.1016/j.jhep.2024.
    PubMed        
    
    

    
    PLoS One

21. BAGER P, Bossen L, Gantzel R, Gronbaek H, et al
    High-dose oral thiamine versus placebo for chronic fatigue in patients with primary biliary cholangitis: A crossover randomized clinical trial.
    PLoS One. 2024;19:e0301354.
    PubMed         Abstract available
    
    
22. CAI W, Qiu T, Hu W, Fang T, et al
    Changes in the intestinal microbiota of individuals with non-alcoholic fatty liver disease based on sequencing: An updated systematic review and meta-analysis.
    PLoS One. 2024;19:e0299946.
    PubMed         Abstract available
    
    
23. CHEN R, An Y, Xu M
    Prognostic difference between surgery and external radiation in patients with stage I liver cancer based on competitive risk model and conditional survival rate.
    PLoS One. 2024;19:e0298014.
    PubMed         Abstract available
    
    
24. AZAMAR-LLAMAS D, Arenas-Martinez JS, Olivas-Martinez A, Jimenez JV, et al
    Impact of COVID-19 vaccination on liver transplant recipients. Experience in a reference center in Mexico.
    PLoS One. 2024;19:e0301198.
    PubMed         Abstract available
    
    
25. RAN S, Song L, Yang H, Yu J, et al
    Piperine alleviates nonalcoholic steatohepatitis by inhibiting NF-kappaB-mediated hepatocyte pyroptosis.
    PLoS One. 2024;19:e0301133.
    PubMed         Abstract available
    
    
26. WILSON EA, Woodbury A, Williams KM, Coopersmith CM, et al
    OXIDATIVE study: A pilot prospective observational cohort study protocol examining the influence of peri-reperfusion hyperoxemia and immune dysregulation on early allograft dysfunction after orthotopic liver transplantation.
    PLoS One. 2024;19:e0301281.
    PubMed         Abstract available
    
    

    
    Radiology

27. YOON JH, Kim YK, Kim JW, Chang W, et al
    Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid-enhanced Liver MRI.
    Radiology. 2024;311:e233114.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.